Phil Tibbo

Related information

• Nova Scotia Early Psychosis Program
• Dr. Tibbo is the Dr. Paul Janssen Chair in Psychotic Disorders, the Director, Nova Scotia Early Psychosis Program and the Co-Director, Nova Scotia Psychosis Research Unit
• CV [PDF - 390KB]
  

Education

B.Sc. Honours - Mount Allison University, NB                        
B.Med.Sc. - Memorial University of Newfoundland                               MD - Memorial University of Newfoundland
FRCPC - University of Alberta, Psychiatry                                               AHFMR - Clinical Research Fellow, University of Alberta Psychiatry

Research interests

Dr. Tibbo investigates psychosis/schizophrenia in the areas of neuroimaging (MRS, DTI), genetics, and non-pharmacological treatment options for schizophrenia. Other projects include the development of a relapse prediction tool for use by clinicians and family members; a tool for monitoring medication side effects; and service delivery/national guidelines for early phase psychosis.

Selected publications

• Tibbo, P., Bernier, D., Hanstock, C.C., Seres, P., Lakusta, B., Purdon, S. (2013)  3-T  proton magnetic spectroscopy in unmedicated first episode psychosis:  A focus on creatine.  Magnetic Resonance in Medicine 69:613-620.
• Malla A, Tibbo P, Chue P, Levy E, Manchanda R, Teehan M, Williams R, Iyer S, Roy M. (2013) Long-acting injectable antipsychotics: Recommendations for clinicians. Can J Psychiatry 2013;58 (5 Suppl 1):30S-35S.
• Crocker CE, Bernier D, Hanstock C, Lakusta B, Purdon SE, Seres P, Tibbo PG. (2014) Prefrontal glutamate levels in early phase schizophrenia and abstinant methamphetamine addiction: A ¹H-MRS study at 3 Tesla. Schizophrenia Research 2014 Aug; 157 (1-3):231-7.
• Cookey J, Bernier D, Tibbo P.  (2014) White matter changes in early phase psychosis and cannabis use: an update and systematic review of diffusion tensor imaging studies. Schizophrenia Research 2014 Jul; 156(2-3):137-42.
• Tibbo P, Malla A, Manchanda R, Williams R, Joober R. (2014) Relapse Risk Assessment in Early Phase Psychosis: The Need for a Reliable and Valid Tool. Canadian Journal of Psychiatry.  (In press)

Selected awards and honors

• 2000-2005 - REACH Innovation Award (Recognition of Excellence and Achievement in Capital Health) - Edmonton Early Psychosis Intervention Clinic (EEPIC)
• 2000-2001-2004/2005 - 2008 -Alberta Heritage Foundation for Medical Research (AHFMR) Clinical Investigator Award
• 2012 - Mental Health Commission of Canada 5^th Anniversary National Mental Health Awards - Research. “Understanding the link between cannabis and psychosis: An awareness strategy for youth” [research lead on project run in collaboration with the Schizophrenia Society of Canada]
• 2013 - Fellow of the Canadian Psychiatric Association awarded by Canadian Psychiatric Association

Memberships

• 1993-present         Canadian Psychiatric Association
• 1997-present         Royal College of Physicians and Surgeons of                                 Canada
• 1999-present         Society of Biological Psychiatry
• 2011-present         Schizophrenia International Research Society (SIRS)
  
• 2013-present         Canadian Consortium for Early Intervention in                             Psychosis

Teaching

• Postdoctoral (6)
• PhD (3)
•  MSc (6)

Service & Activity

• 2004-2010 Vice-Chair/Chair, Royal College of Physicians and Surgeons of Canada (RCPSC) Examination Committee and Board for Psychiatry
• 2012-present Chair, Schizophrenia Society of Canada Foundation
• 2014 Co-Chair, Capital Health Addictions and Mental Health Program (CHAMHP) - Quality Council
• 2014 Co-Chair, Capital Health Addictions and Mental Health Program (CHAMHP) – Pathways Redesign Project for Psychosis
• 2014 Board Member – Canadian Consortium for Early Intervention in Psychosis